Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib

被引：58
|
作者：
Follows, George A. [1 ]
Sims, Hannah [1 ]
Bloxham, David M. [1 ]
Zenz, Thorsten [2 ,3 ]
Hopper, Melanie A. [4 ]
Liu, Hongxiang [5 ]
Bench, Anthony [1 ]
Wright, Penny [5 ]
van't Veer, Mars B. [1 ]
Scott, Mike A. [1 ]
机构：
[1] Cambridge Univ Teaching Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Haematol, Cambridge, England
[2] Natl Ctr Tumour Dis NCT, Dept Translat Oncol, Heidelberg, Germany
[3] German Canc Res Ctr, Heidelberg, Germany
[4] Cambridge Univ Teaching Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Radiol, Cambridge, England
[5] Cambridge Univ Teaching Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Pathol, Cambridge, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 161卷 / 01期
关键词：
hairy cell leukaemia; vemurafenib; BRAF V600E; MUTATIONS;
D O I：
10.1111/bjh.12201
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：150 / 153
页数：4
相关论文
共 50 条
  • [1] Rapid Response of Biallelic BRAF V600E Hairy Cell Leukaemia to Low Dose Vemurafenib
    Sims, Hannah
    Bloxham, David
    Creasey, Hannah
    Bradford, Elaine
    Liu, Hongxiang
    Wright, Penny
    Bench, Anthony
    Hopper, Melanie A.
    van't Veer, Mars
    Crawley, Charles
    Scott, Mike
    Follows, George
    BLOOD, 2012, 120 (21)
  • [2] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Del Bufalo, Francesca
    Ceglie, Giulia
    Cacchione, Antonella
    Alessi, Iside
    Colafati, Giovanna Stefania
    Carai, Andrea
    Diomedi-Camassei, Francesca
    De Billy, Emmanuel
    Agolini, Emanuele
    Mastronuzzi, Angela
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [3] Pyrosequencing of BRAF V600E in routine samples of Hairy Cell Leukaemia identifies CD5+ variant Hairy Cell Leukaemia that lacks V600E
    Lennerz, Jochen K.
    Klaus, Beate M.
    Marienfeld, Ralf B.
    Moeller, Peter
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (02) : 267 - 269
  • [4] Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenib
    van Tilburg, Cornelis M.
    Selt, Florian
    Sahm, Felix
    Baechli, Heidi
    Pfister, Stefan M.
    Witt, Olaf
    Milde, Till
    PEDIATRIC BLOOD & CANCER, 2018, 65 (03)
  • [5] The biology of Hairy cell leukaemia revisited : the constant highlighting of V600E mutation in BRAF
    Troussard, Xavier
    HEMATOLOGIE, 2011, 17 (04): : 256 - 257
  • [6] Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
    Lang, Matthias
    Longerich, Thomas
    Anamaterou, Chrysanthi
    THYROID RESEARCH, 2023, 16 (01)
  • [7] Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype
    Langabeer, S. E.
    O'Brien, D.
    Liptrot, S.
    Flynn, C. M.
    Hayden, P. J.
    Conneally, E.
    Browne, P. V.
    Vandenberghe, E.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 (04) : 417 - 421
  • [8] Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
    Matthias Lang
    Thomas Longerich
    Chrysanthi Anamaterou
    Thyroid Research, 16
  • [9] BRAF V600E AND HAIRY-CELL LEUKEMIA
    不详
    CANCER DISCOVERY, 2011, 1 (02) : 95 - 96
  • [10] Vemurafenib in Melanoma with BRAF V600E Mutation
    Morita, Hiroyuki
    Nagai, Ryozo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1448
12345